Joint-Predominant Rheumatic Complications of Immune Checkpoint Inhibitor Therapy in Patients with Thymic Epithelial Tumors.
Oncologist. 2022 Apr 5;27(4):e353-e356. doi: 10.1093/oncolo/oyac026.
Oncologist. 2022.
PMID: 35380721
Free PMC article.